Date of Award
2021
Document Type
Dissertation/Thesis
Submission Date
October 2026
Thesis/Dissertation Advisor [Chair]
Wetterer, James
Abstract
Coronavirus disease 2019, also known as the COVID-19, is the disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This disease is first identified in Wuhan, China and has spread across the world causing a pandemic. With the majority of countries shutting down and the infection spreading exponentially, countries raced to find safe and effective vaccines. Nearly a year after the first confirmed case in the United States, vaccines were ready to be administered. The three major vaccines in the United States were Pfizer- BioNTech, Johnson and Johnson and the Moderna Vaccines. The Pfizer-BioNTech and the Moderna required two doses whereas the Johnson and Johnson required only one dose. Vaccines around the world were created and administered at an alarming rate, However, it is still insufficient, as only 5% of the global population has been administered as of April 9, 2021
Recommended Citation
Ilamadi, Kartikk Musiri, "The Efficacy of Vaccines for SARS.CoV-2" (2021). Harriet L Wilkes Honors College Theses 2020 - Present. 116.
https://digitalcommons.fau.edu/etd_honors/116
Extent
20 p.
Identifier
FAUHT00152
Comments
Thesis (B.A.)--Florida Atlantic University, Harriet L. Wilkes Honors College, 2021